{"nct_id":"NCT02130193","title":"Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations","status":"COMPLETED","status_verified_date":"2017-04","start_date":"2014-02-13","start_date_type":"ACTUAL","primary_completion_date":"2016-08-29","primary_completion_date_type":"ACTUAL","completion_date":"2016-08-29","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}